1. Introduction {#sec1}
===============

Obesity, a worldwide public health problem, is described as an adiposity-based chronic disease \[[@B1]\]. Currently, guidelines recommended using body mass index (BMI) to classify individuals as having obesity (BMI *⩾*30 kg/m^2^) \[[@B2]\]. Based on the survey conducted previously, the standardized prevalence rates for obesity in adult were 34.9% in United States and 17.7% in China \[[@B3], [@B4]\]. Moreover, it is associated with other health concerns, such as insulin resistance, type 2 diabetes mellitus, cardiovascular disease, and cancer, which increased individuals and societies\' medical burden \[[@B5]\].

Lifestyle modification, pharmacotherapy, and bariatric surgery are considered the mainstay of therapy for obesity \[[@B2]\]. Although diet and exercise play an essential role in the weight management, their precise mode of action remains controversial \[[@B6]\]. Five long-term medicines (naltrexone-bupropion, phentermine-topiramate orlistat, lorcaserin, and liraglutide) have been approved by US Food and Drug Administration (FDA) for the treatment of obesity \[[@B7]\]. The latest research suggested that phentermine-topiramate was associated with the highest possibility of achieving at least 5% weight loss \[[@B7]\]. However, little is known about the long-term safety profile of pharmacotherapy for weight loss. The effectiveness of bariatric procedures for treating obesity has been reported in several randomized controlled trials (RCTs) \[[@B8]--[@B10]\]. Nevertheless, the evidence on cardiovascular disease and mortality remains to be validated \[[@B11]\]. Therefore, it is necessary to explore other forms of alternative therapies which are both safe and effective in preventing gaining weight.

In reviewing the literature, it became evident that acupuncture and related therapies have been wildly used for obesity treatment. As mentioned in the meta-analysis, combination of acupuncture and lifestyle modification is more effective compared with lifestyle modification alone \[[@B12]\]. Results of Yeh\'s research suggested that ear acupoint stimulation had remarkable improvements in the anthropometric parameters of Body Weight (BW), BMI, and so on \[[@B13]\]. In addition, another systematic review performed in 2015 has also shown that clinical efficacy of acupoint catgut embedding therapy was better than that of the control group for simple obesity \[[@B14]\]. However, a major problem is that whether acupuncture or acupuncture-related therapies alone or combined therapy is more effective than lifestyle modification management remains disputable.

By using the technique of network meta-analysis (NMA), both direct and indirect randomized data can be analyzed, and recommended rankings of different treatments can be provided \[[@B15], [@B16]\]. Therefore, we conducted this Bayesian network meta-analysis to analyse both direct and indirect comparisons of acupuncture and related methods for treating obesity. In this paper, changes in BW, BMI, and the rates of complications of included studies were analyzed.

2. Methods {#sec2}
==========

Our research was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Network Meta-Analysis (PRISMA-NMA) checklist \[[@B17]\] (see [Appendix 1](#supplementary-material-1){ref-type="supplementary-material"}).

2.1. Data Sources and Search Strategy {#sec2.1}
-------------------------------------

Three electronic international databases (PubMed/Medline, Embase, and the Cochrane Library) were searched for potential RCTs (randomized controlled trials). We identified articles published from initiation to December 2017 with a limit to studies of RCT and without limitations on language or the form they are published in. The complete search strategies are shown in [Appendix 2](#supplementary-material-1){ref-type="supplementary-material"}.

2.2. Study Selection {#sec2.2}
--------------------

Two researchers (XC and HL) independently identified irrelevant research based on titles and abstracts. Additionally, full-text articles were scanned by these two researchers to identify eligible studies. All disagreements were resolved by consensus and adjudged by a third reviewer (TC) if necessary. In case of duplicate citations, the most updated studies were selected for data extraction.

2.3. Inclusion and Exclusion Criteria {#sec2.3}
-------------------------------------

The studies included in the NMA met the following criteria: (1) the study design must be a randomized controlled clinical trial (RCT); (2) patients diagnosed with simple obesity irrespective of ages and sex as study subjects; diagnostic criteria must be clear and inclusion and exclusion criteria were explicit; (3) at least one of the following efficacy outcomes or safety endpoints was included: BW, BMI, and adverse events; (4) participants in the experimental group have received acupuncture and related treatments (specifically, classical body acupuncture; electroacupuncture auricular acupoint stimulation; acupoint catgut embedding and warming acupuncture) alone or in combination; (5) English or Chinese language studies.

The following were excluded: (1) self-control and non-RCTs; (2) preclinical studies, systematic reviews, case reports, and meta-analyses; (3) reports without sufficient and clear original data; (4) participants having received other forms of acupuncture such as transcutaneous electrical nerve stimulation or laser acupuncture; (5) duplicate studies and studies reporting the same results.

2.4. Data Collection and Quality Assessment {#sec2.4}
-------------------------------------------

According to a standard data collection sheet, two investigators (TC and XZ) independently extracted the following data: (1) main characteristics of included randomized controlled trials (i.e., year of publication, type of intervention, patients characteristics, types of outcome, and reported adverse events); (2) details of acupuncture and related interventions (i.e., frequency and duration of acupuncture sessions, names of acupuncture points used, and retention time); (3) clinical outcome (i.e., summaries of mean, standard difference, and sample size between treatment groups). In some trials, the change between baseline and after treatment was failed to present. Using the methods recommended in the Cochrane Handbook for Systematic Reviews of Interventions (version 5.1) \[[@B18]\], the missing data was estimated using the following formula:$$\begin{matrix}
{{\overset{-}{X}}_{change}\operatorname{} = {\overset{-}{X}}_{post - treatment} - {\overset{-}{X}}_{baseline}} \\
 \\
\end{matrix}$$$$\begin{matrix}
{SD_{change}\operatorname{} = \sqrt{\left( {SD}_{baseline} \right)^{2} + \left( {SD}_{post - treatment} \right)^{2} - 2 \times r \times {SD}_{baseline} \times {SD}_{post - treatment}}} \\
 \\
\end{matrix}$$where r is a correlation coefficient with a value of 0.5 \[[@B19]\]. For each included RCT, two researches (XT and XC) independently assessed their risk of bias by the Cochrane Collaboration tool \[[@B20]\]. Bias risks of each study were assessed from six aspects: random sequence generation, allocation concealment, blinding of participants and investigators, blinding of outcome assessment, incomplete outcome data addressed, and selective outcome reporting, while ranked in high risk, low risk, and unclear risk.

2.5. Statistical Analysis {#sec2.5}
-------------------------

Firstly, standard pairwise meta-analysis was initially performed using the Review Manager (Version 5.3, Cochrane Collaboration, Oxford, UK). We calculated I-square (I^2^) test to assess heterogeneity among RCTs \[[@B21]\]. To be specific, when there was I^2^ \> 50%, they were analysed using a random effects model; otherwise, a fixed effect model was chosen. Subgroup analyses were conducted according to the type of acupuncture treatment and the treatment of control group. Mean difference (MD) with 95% confidence intervals (CI) was used to analyze continuous data. We generated forest plots to illustrate the relative strength of curative effects.

Second, to indirectly compare the effectiveness among treatments of acupuncture and related therapies, we did a random effects model NMA within a Bayesian framework, by using WinBUGS (Version 1.4.3, MRC Biostatistics Unit, Cambridge, UK) \[[@B22], [@B23]\]. Models were computed with Markov chain Monte Carlo (MCMC) simulation methods, using four chains with overdispersed initial values. We utilized the Markov chains for 50,000 simultaneous iterations after the first 20000 iterations were discarded because they may have an influence on the arbitrary value. In this process, the convergence of the model was assessed by the Brooks-Gelman-Rubin (BGR) method; a value of potential scale reduction factor (PSRF) close to 1 indicated the better convergence \[[@B24]\]. The continuous outcome was measured by a standard mean difference (SMD) with a 95% credible intervals (CrI) for indirect comparisons.

Finally, plot of surface under the cumulative ranking curve (SUCRA) was generated using the STATA software (Version 13.0; Stata Corporation, College Station, Texas, USA), which indicated the probability of each intervention of being ranked best \[[@B25]\]. In our study, higher SUCRA scores mean the higher rank of the treatment \[[@B15]\]. A Z value and its corresponding p-value were calculated, and an R value less than 0.05 indicated a statistically significant difference.

3. Results {#sec3}
==========

3.1. Study Search {#sec3.1}
-----------------

We performed this research on Dec 26 2017. As shown in [Figure 1](#fig1){ref-type="fig"}, a total of 1050 records were initially identified from the databases. 675 studies left after duplicates were removed. 577 records were excluded after carefully scanning titles and abstracts. Finally, 34 trials with 2283 participants were included in our NMA \[[@B26]--[@B59]\], covering 8 groups, manual acupuncture; electroacupuncture; auricular acupoint stimulation; acupoint catgut embedding; pharmacotherapy; warming acupuncture; lifestyle modification; placebo.

3.2. Study Description {#sec3.2}
----------------------

Main characteristics of included RCTs were shown in [Table 1](#tab1){ref-type="table"}. The participants were from Australia \[[@B28]\], the United States \[[@B26]\], Turkey \[[@B46]\], Korea \[[@B51]\], Iran \[[@B36]\], Egypt \[[@B48]\], and China. Age of participants ranged from 15 to 70 years, while the sample size of the studies ranged from 12 to 86. Among the included RCTs, there were one four-arm trials, 5 three-arm trials, and 28 two-arm trials. Fourteen studies compared acupuncture to placebo. Ten studies compared acupuncture to lifestyle intervention. Six studies compared combined therapies to acupuncture alone. Details about acupuncture points used, retention time, frequency, and duration of acupuncture sessions were shown in [Table 2](#tab2){ref-type="table"}. In these research, 30 articles \[[@B26]--[@B30], [@B32], [@B34]--[@B38], [@B41]--[@B59]\] reported the weight loss, while 25 articles reported the change in BMI. The details of mean, standard difference (SD), and sample size between different groups for eligible studies are summarized in [Appendix 3](#supplementary-material-1){ref-type="supplementary-material"}. The Cochrane risk of bias assessment was presented in [Table 3](#tab3){ref-type="table"}. Furthermore, the network plot of included comparisons was shown in [Figure 2](#fig2){ref-type="fig"}.

3.3. Pairwise Meta-Analyses {#sec3.3}
---------------------------

### 3.3.1. Body Weight {#sec3.3.1}

A direct pairwise meta-analysis showed that acupuncture and related therapies showed a greater BW reduction than lifestyle modification (MD: 1.66; 95% Confidence interval, 0.63to2.70) and placebo (MD: 1.15; 95% CI, 0.67to1.63). When compared to acupuncture, combination of acupuncture and related theories showed a marginally stronger effect in weight loss (MD: 1.56; 95% CI, 0.07to3.05). There was no statistically significant difference between combination of acupuncture and related theories and pharmacotherapy in their effectiveness in BW (MD: 2.44; 95% CI, -1.98to6.86). ([Table 4](#tab4){ref-type="table"})

*BMI*. As for the comparison in reducing BMI, acupuncture and related therapies were found to be marginally superior to lifestyle modification (MD: 1.17; 95% CI, 0.09to2.26) and placebo (MD: 0.57; 95% CI, 0.40to0.74). The remaining direct comparisons did not show significant differences ([Table 4](#tab4){ref-type="table"}).

3.4. Network Meta-Analysis {#sec3.4}
--------------------------

### 3.4.1. Body Weight {#sec3.4.1}

The NMA showed that all treatments other than acupuncture combined lifestyle modification were more efficacious than lifestyle modification. Three treatments were significantly more effective than placebo. Specifically, acupoint catgut embedding (SMD: 1.26; 95% credible interval, 0.46to2.06), acupuncture (SMD: 2.72; 95% CrI, 0.06to5.29), and combination of acupuncture and related therapies (SMD: 3.65; 95% CrI, 0.96to6.94). Furthermore, moxibustion with warming needle was associated with a significantly improvement than lifestyle modification (SMD: -5.24; 95% CrI, -10.15to-0.55) ([Table 5](#tab5){ref-type="table"}).

### 3.4.2. BMI {#sec3.4.2}

Four treatments showed superiority over placebo, including acupoint catgut embedding (SMD: 1.31; 95% CrI, 0.36to2.06), acupuncture (SMD: 1.94; 95% CrI, 0.83to3.00), combination of acupuncture and related theories (SMD: 3.65; 95% CrI, 0.96to6.94), and electroacupuncture (SMD: 1.28; 95% CrI, 0.43to2.11). Four treatments were significantly more effective than lifestyle modification, including acupoint catgut embedding (SMD: 0.63; 95% CI, 0.25to1.11), acupuncture (SMD: 1.28; 95% CrI, 0.43to2.06), combination of acupuncture and related theories (SMD: 1.44; 95% CrI, 0.64to2.38), and electroacupuncture (SMD: 0.60; 95% CrI, 0.03to1.22). Also, the combination of acupuncture and related theories and acupuncture alone were both superior to the acupuncture combined lifestyle modification in their ability to reduce body mass index (SMD = -1.76, 95% CrI =−2.96 to −0.62; SMD = −1.59, 95% CrI = −2.71to −0.34) ([Table 5](#tab5){ref-type="table"}).

3.5. Ranking {#sec3.5}
------------

### 3.5.1. Body Weight {#sec3.5.1}

Ranking of the different treatment methods was displayed [Figure 3](#fig3){ref-type="fig"}. The results suggested that, on the aspect of weight loss, combination of acupuncture and related therapies was ranked the optimal method, the best, (88.7%), followed by moxibustion with warming needle (87.8%), manual acupuncture (70.5%), acupoint catgut embedding (ACE,62.1%), auricular acupoint stimulation (AAS,48.3%), electro acupuncture (EA,46.3%), pharmacotherapy (41.9%), acupuncture combined lifestyle modification (AR+LM,31.2%), placebo acupuncture/sham acupuncture (16.8%), and lifestyle modification (LM,6.4%) which was ranked as the worst.

### 3.5.2. BMI {#sec3.5.2}

The results suggested that, on the aspect of BMI, combination of acupuncture and related therapies was ranked the optimal method, the best, (90.2%), followed by manual acupuncture (83.3%), pharmacotherapy (64.7%), acupoint catgut embedding (58.6%), auricular acupoint stimulation (55.7%), electroacupuncture (52.1%), placebo acupuncture/sham acupuncture (25.1%), acupuncture combined lifestyle modification (16.9%), and lifestyle modification (3.4%) which was ranked as the worst.

3.6. Inconsistency Assessment {#sec3.6}
-----------------------------

### 3.6.1. Body Weight {#sec3.6.1}

The Z test illustrates the inconsistency of the NMA specifically ([Appendix 4](#supplementary-material-1){ref-type="supplementary-material"}). For the inconsistency test outcome of BW, 95% CI of 8 loops was included 0, which reflected that no significant inconsistency was found. However, another 2 loops (ACE-Acupuncture-Combined therapies; ACE-Combined theories-EA) were found statistical inconsistency between direct and indirect comparisons.

### 3.6.2. BMI {#sec3.6.2}

For the inconsistency test outcome of body mass index, 95% CI of all loops (acupuncture -combined theories-EA; acupuncture-EA-placebo; AR+LM -EA- LM-placebo; ACE-acupuncture-EA; AAS-EA-LM; AAS-AR+LM-LM-placebo; AAS-EA-placebo) were included 0, which reflected that no significant inconsistency was found.

3.7. Safety {#sec3.7}
-----------

Ten RCTs \[[@B26]--[@B28], [@B31], [@B32], [@B35], [@B36], [@B38], [@B39], [@B45]\] reported adverse events, while no major complications were noticed in all included studies. Three included studies \[[@B35], [@B36], [@B39]\] reported that no adverse effects were noted in both experimental group and placebo group. In one included RCT, there were two patients reporting mild ecchymosis and one abdominal discomfort case reported as adverse events after electroacupuncture treatment; no case was reported in the lifestyle modification group \[[@B27]\]. In another study, there were seven subjects in group auricular acupoint stimulation and two subjects in group placebo had mild tenderness \[[@B32]\].

4. Discussion {#sec4}
=============

The aim of this study was to identify the efficacy and safety of acupoint stimulation therapy for obesity. In this NMA, the association of each acupuncture and related therapies with relative weight loss was compared by the combination of direct and indirect evidence from 34 RCTs in 2283 obese patients.

This study has three key findings. First, ranking graphs of the primary outcome suggested that the combination of acupuncture and related therapies was the most effective in losing weight and improving BMI. Second, compared with placebo or sham acupuncture, combination of acupuncture-related therapies, manual acupuncture, acupoint catgut embedding, auricular acupuncture therapy, and electroacupuncture are all associated with higher odds of achieving weight loss. Third, combination of acupuncture and related therapies, manual acupuncture, pharmacotherapy, acupoint catgut embedding, auricular acupoint stimulation, and electroacupuncture were superior to lifestyle intervention.

Lifestyle modification, like diet intervention and physical activity, is recommended as safe and effective way to lose weight \[[@B60]\]. Results of direct and indirect evidence suggest acupuncture and related theories had significant beneficial effects in dealing with obesity compared with lifestyle modification. Both experimental and clinical data prove the efficacy of acupuncture for obesity \[[@B61]\]. Experimental data suggests that acupuncture exerts beneficial effects on weight loss \[[@B62], [@B63]\]. The majority of clinical evidence suggests that acupuncture and related therapies reduced more weight than sham control group \[[@B26], [@B28], [@B31], [@B32]\], which are consistent with our results. Previous animal studies have observed that the expression of obesity-related peptides was upregulated in the hypothalamus after acupuncture treatment, which induced less food intake and weight loss \[[@B62], [@B64], [@B65]\]. Similarly, significant decreases in plasma leptin level were observed after EA treatment in obese patients \[[@B46]\]. With regard to insulin level, several experimental studies reported that EA can improve insulin sensitivity \[[@B66], [@B67]\]. However, results from clinical trials regarding insulin levels are controversial. Cabioğlu MT reported that EA increased insulin level compared with control group \[[@B56]\], but Gucel F indicated that acupuncture decreased insulin level \[[@B46]\]. As to effects on lipid metabolism, acupuncture was reported to be effective in decreasing total cholesterol (TC), triglycerides (TG) and LDL-C concentrations \[[@B68], [@B69]\] of obese rat. Significant decreases in TC \[[@B55]\], TG \[[@B35]\], and LDL-C \[[@B55]\] were observed whereas no changes in HDL-C \[[@B55]\] levels were observed in clinical trials. Furthermore, experimental studies suggest that there was significant decrease in serum TNF*α* after EA \[[@B70]\]. Except for the noted mechanisms, EA can also induce white adipose tissue (WAT) browning via increasing uncoupling protein-1 (UCP1) gene expression \[[@B71]\].

This NMA has several attractive advantages. We focused on simple obesity patients without complication, which decreased the heterogeneity and improve the quality of this study. In addition, we compared acupuncture and acupuncture-related therapies with the first-line treatment for obesity-lifestyle modification with a Bayesian framework. The rank test of effectiveness provides data to favour acupuncture and acupuncture-related therapies. Lastly, we conducted a comprehensive search and included all eligible studies. We compared five different acupuncture treatments (manual acupuncture; electro acupuncture; auricular acupoint stimulation; acupoint catgut embedding; moxibustion with warming needle) in the clinical effectiveness in treating patients with obesity.

However, this study has several limitations. First, we failed to evaluate the safety of each acupoint stimulation therapy due to the limited data in primary studies. Future trials should report adverse events clearly to improve the quality of study design. Second, unaddressed concerns still exist regarding the long-term effects of using acupuncture and acupuncture-related therapies on weight management in a clinical setting. The duration of acupuncture sessions and follow-up duration of most included trials ranging from four weeks to twelve weeks. Further clinical evaluation of acupuncture for obesity with longer follow-up appears warranted. Third, blinding of patients and researches was not applied among included studies and the included trials were mainly conducted in China, which may lead to publication bias \[[@B72]\]. Fourth, included study in our NMA lack of research compares the effectiveness between acupuncture, pharmacotherapy, and different types of combination of acupuncture. Further confirmatory comparative effectiveness trials should compare different types of combination of acupuncture. Except one study compared acupuncture and pharmacotherapy \[[@B29]\], additional research is needed to further explore. Finally, we use R-value to estimate the changes in standard deviations (SD), which might enlarge the SD compared with the originals values.

Overall, our results indicate that combination of acupuncture and related therapies ranks as the optimal method for reducing both weight and BMI. Further studies will clarify which combination of acupuncture and related therapies is better.
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Appendix 1: the PRISMA-NMA checklist treatment groups for included studies in a network meta-analysis. Appendix 2: search strategies for RCTs on acupuncture for obesity. Appendix 3: summaries of mean, standard difference, and sample size between treatment groups for included studies in a network meta-analysis. Appendix 4: inconsistency test.

###### 

Click here for additional data file.

![PRISMA flow chart.](ECAM2018-9569685.001){#fig1}

![*Network plot.* BMI: body mass index; LM: lifestyle modification; AAS: auricular acupoint stimulation; EA: electroacupuncture; ACE: acupoint catgut embedding; WA: warming acupuncture; AR: acupuncture and related therapies; combined therapies: combination of acupuncture and related therapies.](ECAM2018-9569685.002){#fig2}

![*Surface under the cumulative ranking curves*. LM: lifestyle modification; AAS: auricular acupoint stimulation; EA: electroacupuncture; ACE: acupoint catgut embedding; WA: warming acupuncture; AR: acupuncture and related therapies; combined therapies: combination of acupuncture and related therapies; PLA: placebo; PHA: pharmacotherapy.](ECAM2018-9569685.003){#fig3}

###### 

Main characteristics of included randomized controlled trials.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study ID and Country                         Sample size R/A            Age: mean (SD) or range\    Intervention           Control           Adverse events reported\                                         Type of outcomes
                                                                          R/A                                                                  R/A                                                              
  -------------------------------------------- -------------------------- --------------------------- ---------------------- ----------------- ---------------------------------------------------------------- ------------------
  Allison et al. \[[@B17]\] 1995, USA          35/34                      19 - 70                     AAS                    Placebo           Redness, pain, bleeding                                          BW,

                                                                                                                                                                                                                

  Hsu et al. \[[@B18]\] 2005, Taiwan           24/22                      41.5(11.2)/41.0 (10.0)      EA                     LM                Ecchymosis(2), abdominal discomfort(1)/None                      BW, BMI

                                                                                                                                                                                                                

  Richards et al. \[[@B19]\] 1998, Australia   28/32                      44.1 (11.7)/43.0 (13.6)     AAS                    Placebo           intercurrent illness and discontinued(1)/None                    BW

                                                                                                                                                                                                                

  He et al. \[[@B20]\] 2008, China             40/40                      18 - 50                     Combined therapies\#   Pharmacotherapy   NR                                                               BW, BMI

                                                                                                                                                                                                                

  Li et al. \[[@B21]\] 2006, China             26/30                      16.00(1.38)/16.00(1.95)     EA                     LM                NR                                                               BMI

  29/30                                        15.00(2. 04)/16.00(1.95)   AAS                                                                                                                                   

                                                                                                                                                                                                                

  Tong et al. \[[@B22]\] 2011, China           76/42                      35.08(9.31)/34.60(8. 55)    Acupuncture            Placebo           Adverse events VAS                                               BMI

                                                                                                                                                                                                                

  Hsu et al. \[[@B23]\] 2009, Taiwan           23/22                      40.0 (10.5)/39.4 (13.6)     AAS                    Placebo           Minor-inflammation(1), mild tenderness (7)/mild tenderness (2)   BW, BMI

                                                                                                                                                                                                                

  Hsieh et al. \[[@B24]\] 2010, Taiwan         26/26                      18 - 20                     AAS                    Placebo           NR                                                               BMI

                                                                                                                                                                                                                

  Hsieh et al. \[[@B25]\] 2011, Taiwan         27/28                      18 - 20                     AAS                    Placebo           NR                                                               BW

                                                                                                                                                                                                                

  Abdi et al. \[[@B26]\] 2012, Iran            86/83                      37.29(1.0)/38.73 (1.1)      AAS                    Placebo           None                                                             BW, BMI

                                                                                                                                                                                                                

  Darbandi et al. \[[@B27]\] 2012, Iran        43/43                      37.57(9.26)/37.65(9.71)     AR+ LM                 Placebo           None                                                             BW, BMI,

                                                                                                                                                                                                                

  He et al. \[[@B28]\] 2012, China             30/30                      18-54                       AR+ LM                 LM                NR                                                               BW, BMI

                                                                                                                                                                                                                

  Lien et al. \[[@B29]\] 2012, Taiwan          24/23                      39.2(11.6)/40.7 (9.7)       AAS                    Placebo           Dizziness (1)/None                                               BW, BMI

                                                                                                                                                                                                                

  Darbandi et al. \[[@B30]\] 2014, Iran        20/20                      38.0(0.9)/38.0(1.3)         EA                     Placebo(EA)       None                                                             BW, BMI

  20/20                                        39.0(1.8)/37.9(1.5)        AAS                         Placebo(AAS)                                                                                              

                                                                                                                                                                                                                

  Yeh et al. \[[@B31]\] 2015, Taiwan           36/34                      29.9 (7.7)/32.8 (9.5)       EA                     Placebo           NR                                                               BMI

                                                                                                                                                                                                                

  Chen et al. \[[@B32]\] 2007, China           40/40                      43.1(13.6)/44.6(10.3)       ACE                    Acupuncture       NR                                                               BW, BMI

                                                                                                                                                                                                                

  Huang et al. \[[@B33]\] 2011, China          30/30                      NR                          ACE                    EA                NR                                                               BW, BMI

                                                                                                                                                                                                                

  Tang et al. \[[@B34]\] 2009, China           33/32                      21-54/22-55                 Combined therapies     EA                NR                                                               BW, BMI

                                                                                                                                                                                                                

  Shi et al, \[[@B35]\] 2006, China            40/42                      17-49/18-51                 Combined therapies     EA                NR                                                               BW, BMI

                                                                                                                                                                                                                

  Hsu et al. \[[@B36]\] 2005, Taiwan           22/20                      40.0 (11.5)/41.3 (9.9)      EA                     LM                mild Ecchymosis(3), abdominal discomfort(1)/None                 BW, BMI

                                                                                                                                                                                                                

  Güçel et al. \[[@B37]\] 2012, Turkey         20/20                      34.6±6.3/36.8±7.8           Acupuncture            Placebo           NR                                                               BW, BMI

                                                                                                                                                                                                                

  Deng et al. \[[@B38]\] 2014, China           30/30                      32(7)/33(7)                 Combined therapies     Acupuncture       NR                                                               BW

  30/30                                        32(7)/33(8)                ACE                                                                                                                                   

                                                                                                                                                                                                                

  Hassan et al. \[[@B39]\] 2014, Egypt         21/30                      45.00 (9.32)/43.47 (9.59)   AR+ LM                 LM                NR                                                               BW, BMI

                                                                                                                                                                                                                

  He et al. \[[@B40]\] 2014, China             28/28                      NR                          Combined therapies     Acupuncture       NR                                                               BW, BMI

                                                                                                                                                                                                                

  Wang et al. \[[@B41]\] 2013, China           45/45                      31(10)/32(12)               EA                     Acupuncture       NR                                                               BMI

                                                                                                                                                                                                                

  Sujung et al. \[[@B42]\] 2014, South Korea   22/15                      34.7(11.9)/42.7(10.2)       AAS                    Placebo           NR                                                               BW, BMI

                                                                                                                                                                                                                

  Bu et al. \[[@B43]\] 2007, China             32/23                      32.1(1.1)/33.4(1.3)         Combined therapies     Acupuncture       NR                                                               BW, BMI

                                                                                                                                                                                                                

  Shi et al. \[[@B44]\] 2005, China            36/32                      19\~58/18\~56               WA                     EA                NR                                                               BW

                                                                                                                                                                                                                

  Yang et al. \[[@B45]\] 2010, China           31/30                      18\~42/18\~48               AR+ LM                 LM                NR                                                               BW

                                                                                                                                                                                                                

  Cabioglu et al. \[[@B46]\] 2005, Turkey      22/12                      39.8(5.3)/43.3(4.3)         EA                     Placebo           NR                                                               BW

  22/21                                        39.8(5.3)/42.7(3.9)        LM                                                                                                                                    

                                                                                                                                                                                                                

  Cabioglu et al. \[[@B47]\] 2006, Turkey      20/15                      42.1(4.4)/41.8(4.6)         EA                     Placebo           NR                                                               BW

  20/15                                        42.1(4.4)/42.9 (4.3)       LM                                                                                                                                    

                                                                                                                                                                                                                

  Cabioglu et al. \[[@B48]\] 2008, Turkey      20/15                      40.55 (5.30)/41.47 (4.61)   EA                     Placebo           NR                                                               BW

  20/23                                        40.55 (5.30)/42.91(4.02)   LM                                                                                                                                    

                                                                                                                                                                                                                

  Darbandi et al. \[[@B49]\] 2013, Iran        42/44                      36.50 (9.26)/36.48 (8.69)   AR+ LM                 Placebo           NR                                                               BW, BMI

                                                                                                                                                                                                                

  Fogarty et al. \[[@B50]\] 2015, Australia    19/16                      \>18                        AR+ LM                 Placebo           NR                                                               BMI
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BW: body weight; BMI: body mass index; LM: lifestyle modification; AAS: auricular acupoint stimulation; EA: electroacupuncture; ACE: acupoint catgut embedding; WA: warming acupuncture; AR: acupuncture and related therapies; \#combination of acupuncture and related therapies.

###### 

Descriptions of the included acupuncture and related therapies.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study ID (Country)                Style of acupuncture                                                                                               Names of acupuncture points used                                                                                                                 Retention time                                                                                      Frequency & duration of Acupuncture sessions
  --------------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Allison et al. 1995, USA          AAS                                                                                                                NR                                                                                                                                               2-3 min                                                                                             3 sessions daily for 12 weeks

                                                                                                                                                                                                                                                                                                                                                                                                            

  Hsu et al. 2005, Taiwan           EA                                                                                                                 Qiai(REN9), Shuifen(REN9)\                                                                                                                       40 min                                                                                              2 sessions weekly for 6 weeks
                                                                                                                                                       Shuidao(ST28), Siman(K14)\                                                                                                                                                                                                                           
                                                                                                                                                       Zusanli(ST26), Fenglong(ST40) Sanginjao(SP6)                                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                                                            

  Richards et al. 1998, Australia   AAS                                                                                                                Shenmen(TF4), Stomach(CO4)                                                                                                                       15-20 min                                                                                           2 sessions daily for 4 weeks

                                                                                                                                                                                                                                                                                                                                                                                                            

  He et al. 2008, China             Combined therapies\#                                                                                               Ear acupressure:\                                                                                                                                Ear acupressure:3 days Body acupuncture:30 min                                                      Ear acupressure:1 session every 3 days with a total of 10 sessions\
                                                                                                                                                       Shenmen(TF4), Neifenmi(CO18),\                                                                                                                                                                                                                       Body acupuncture: The first 5 days of treatment 1 time, 5 days after treatment 1, 1 month, for a course of treatment.
                                                                                                                                                       Pi(CO13), Wei(CO14),\                                                                                                                                                                                                                                
                                                                                                                                                       Sanjiao(CO17), Dachang(CO7),\                                                                                                                                                                                                                        
                                                                                                                                                       Naodian\                                                                                                                                                                                                                                             
                                                                                                                                                       Body acupuncture:\                                                                                                                                                                                                                                   
                                                                                                                                                       Tianshu(ST25), Guanyuan(RN4) Sanyinjiso(SP9), Fenglong(ST40) Zusanli(ST36)                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                            

  Li et al. 2006, China             EA                                                                                                                 Sanginjao(SP6), Tianshu(ST25) Zusanli(ST36), Quchi(LI11)\                                                                                        10 min                                                                                              1 session daily with a total of 60 sessions, 2 days rest in-between 10 sessions
                                                                                                                                                       Fenglong(ST40), Neiting(ST44)\                                                                                                                                                                                                                       
                                                                                                                                                       Zhongwan(CV12), Pishu(BL20) Shenshu(BL23), Qihai(CV6) Yinlingquan(SP9), Shangjuxu(ST37) Taichong( LR3)                                                                                                                                               

  AAS                               Hunger point Pizhixia(AT4) Shenmen(TF4), Shenshangxian(TG2P) Sanjiao(CO17), Pi(CO13) Wei(CO14), Fei(CO14)\         15-20 min                                                                                                                                        1 session daily with a total of 10 sessions for 10 weeks, 2 day rest in-between 10 sessions         
                                    Kou(CO1), Dachang(CO7) Zhichangxiduan(HX2)                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                            

  Tong et al. 2011, China           Acupuncture                                                                                                        Zhongwan(CV12), Zhongji(CV3) Daheng(SP15), Xiawan(CV10) Shimen(CV5), Tianshu(ST25)\                                                              30 min                                                                                              1 session every other day for a total of 5 weeks with 12 sessions
                                                                                                                                                       Liangqiu(ST34), Zusanli(ST36) Yinlingquan(SP9)                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                            

  Hsu et al. 2009, Taiwan           AAS                                                                                                                Hunger point, Shenmen point(TF4) Stomach point(CO4),\                                                                                            3 days                                                                                              2 sessions weekly for a total of 6 weeks with 12 sessions
                                                                                                                                                       Endocrine point(CO18)                                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                            

  Hsieh et al. 2010, Taiwan         AAS                                                                                                                NR                                                                                                                                               2/3 days                                                                                            1 session weekly for 10 sessions

                                                                                                                                                                                                                                                                                                                                                                                                            

  Hsieh et al. 2011, Taiwan         AAS                                                                                                                NR                                                                                                                                               NR                                                                                                  1 session weekly for a total of eight weeks

                                                                                                                                                                                                                                                                                                                                                                                                            

  Abdi et al. 2012, Iran            AAS                                                                                                                Shenmen(TF4), Stomach(CO4)\                                                                                                                      3 days                                                                                              Twice a week for a total of 6 weeks
                                                                                                                                                       Hunger point Mouth(CO1)\                                                                                                                                                                                                                             
                                                                                                                                                       Centre of ear(HX1), Sanjiao(CO17)                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                            

  Darbandi et al. 2012, Iran        AAS                                                                                                                Shenmen(TF4), Stomach(CO4) Hunger point Mouth(CO1) Centreof ear(HX1), Sanjiao(CO17)                                                              3 days                                                                                              Twice a week for a total of 6 weeks

                                                                                                                                                                                                                                                                                                                                                                                                            

  He et al. 2012, China             AAS                                                                                                                Hunger point Stomach(CO4)\                                                                                                                       3 days                                                                                              3 times a day for 4 weeks
                                                                                                                                                       Spleen(CO14), LargeIntestine(CO7)\                                                                                                                                                                                                                   
                                                                                                                                                       Endocrine(CO18), Shenmen(TF4)                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                            

  Lien et al. 2012, Taiwan          AAS                                                                                                                Shenmen point(TF4), Stomach point(CO4)\                                                                                                          NR                                                                                                  3 session weekly with a total of 12 sessions for 4 weeks
                                                                                                                                                       Hunger point, Endocrine point(CO18)                                                                                                                                                                                                                  

  Placebo                           Shenmen point(TF4), Stomach point(CO4)\                                                                            NR                                                                                                                                               3 sessions weekly with a total of 12 sessions for 4 weeks                                           
                                    Hunger point, Endocrine point(CO18)                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                            

  Darbandi et al. 2014, Iran        EA                                                                                                                 Tianshu (ST-25), Weidao(GB28)\                                                                                                                   20 min                                                                                              2 sessions weekly for a total of 6 weeks
                                                                                                                                                       Zhongwan(REN12), Shuifen(REN9) Guanyuan(REN4), Sanyinjiao(SP6) Quchi(LI11), Fenlong(ST40) Qihai(REN6), Yinlingquan (SP9)                                                                                                                             

  AAS                               Shenmen (TF4), Stomach (CO4)\                                                                                      3 days                                                                                                                                           2 sessions weekly for a total of 6 weeks                                                            
                                    Hunger point, Mouth (CO1)\                                                                                                                                                                                                                                                                                                                                              
                                    Center of ear (HX1), Sanjiao (CO17)                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                            

  Yeh et al. 2015, Taiwan           EA                                                                                                                 Shenmen (TF4), Stomach CO4) Endocrine (CO18)\                                                                                                    20 min                                                                                              NR
                                                                                                                                                       Hunger point                                                                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                                                            

  Chen et al. 2007, China           ACE                                                                                                                Liangqiu(ST34), Zhongwan(CV12) Tianshu(ST25), Shuifen(CV9) Fenglong(ST40)                                                                        A week                                                                                              1 session weekly with a total of 30 sessions for 4 weeks

  Acupuncture                       Liangqiu(ST34), Zhongwan(CV12) Tianshu(ST25), Shuifen(CV9) Fenglong(ST40)                                          45 min                                                                                                                                           The first 5 days are 1 times a day, and 1 time after 5 days, 1 month is 1 course of treatment.      

                                                                                                                                                                                                                                                                                                                                                                                                            

  Huang et al. 2011, China          ACE                                                                                                                One set is Tianshu(ST25)\                                                                                                                        24 hour                                                                                             1 session weekly with a total of 7 sessions for 60 days
                                                                                                                                                       Zhongwan(CV12), Guanyuan(CV4)\                                                                                                                                                                                                                       
                                                                                                                                                       Zusanli(ST36), Weishu(BL21)\                                                                                                                                                                                                                         
                                                                                                                                                       Ashixue                                                                                                                                                                                                                                              

  EA                                Zhongwan(CV12), Tianshu(ST25)\                                                                                     30 min                                                                                                                                           3 sessions weekly with a total of 12 sessions for 60 days                                           
                                    Daheng(SP15), Shuifen(CV9)\                                                                                                                                                                                                                                                                                                                                             
                                    QIhai(CV6), Guanyuan(CV4)\                                                                                                                                                                                                                                                                                                                                              
                                    Zusanli(ST36), Ashixue                                                                                                                                                                                                                                                                                                                                                  

                                                                                                                                                                                                                                                                                                                                                                                                            

  Tang et al. 2009, China           Combined therapies                                                                                                 EA:\                                                                                                                                             EA:30 min                                                                                           EA:The first 3 days are 1 times a day, and 1 time after 3 days, 15 days is 1 course of treatment.\
                                                                                                                                                       Zhongwan(CV12), Xiawan(CV10)\                                                                                                                                                                                                                        ACE:After the first acupoint catgut embedding for 3 consecutive times, the interval is buried for the second time after 15 days, and the acupuncture is performed for the third time after the end of the treatment period.
                                                                                                                                                       Guanyuan(CV4), Tianshu(ST25)\                                                                                                                                                                                                                        
                                                                                                                                                       Shuifen(CV9), Sanyinjiao(SP6)\                                                                                                                                                                                                                       
                                                                                                                                                       Zusanli(ST36), Xuehai(SP10)\                                                                                                                                                                                                                         
                                                                                                                                                       Xinshu(BL15), Geshu(BL17) Pishu(BL20)\                                                                                                                                                                                                               
                                                                                                                                                       ACE:\                                                                                                                                                                                                                                                
                                                                                                                                                       Zhongwan(CV12), Tianshu(ST25)\                                                                                                                                                                                                                       
                                                                                                                                                       Qihai(CV6), Tianshu(ST25)\                                                                                                                                                                                                                           
                                                                                                                                                       Liangqiu(ST34), Zusanli(ST36)\                                                                                                                                                                                                                       
                                                                                                                                                       Gongsun(SP4), Xinshu(BL15)\                                                                                                                                                                                                                          
                                                                                                                                                       Pishu(BL20)                                                                                                                                                                                                                                          

  EA                                Zhongwan(CV12), Xiawan(CV10)\                                                                                      30 min                                                                                                                                           The first 3 days are 1 times a day, and 1 time after 3 days, 15 days is 1 course of treatment.      
                                    Guanyuan(CV4), Tianshu(ST25)\                                                                                                                                                                                                                                                                                                                                           
                                    Shuifen(CV9), Sanyinjiao(SP6)\                                                                                                                                                                                                                                                                                                                                          
                                    Zusanli(ST36), Xuehai(SP10)\                                                                                                                                                                                                                                                                                                                                            
                                    Xinshu(BL15), Geshu(BL17)\                                                                                                                                                                                                                                                                                                                                              
                                    Pishu(BL20)                                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                            

  Shi et al. 2006, China            Combined therapies                                                                                                 Zhongwan(CV12), Xiawan(CV10)\                                                                                                                    30 min                                                                                              EA:The first 3 days are 1 times a day, and 1 time after 3 days, 15 days is 1 course of treatment.\
                                                                                                                                                       Qihai(CV6), Zhongji(CV3)\                                                                                                                                                                                                                            ACE: After the first acupoint catgut embedding for 3 consecutive times, the interval is buried for the second time after 15 days, and the acupuncture is performed for the third time after the end of the treatment period.
                                                                                                                                                       Tianshu(ST25), Daheng(SP15)\                                                                                                                                                                                                                         
                                                                                                                                                       Liangmen(ST21), Huaroumen(ST24)\                                                                                                                                                                                                                     
                                                                                                                                                       Shuidao(ST28), Quchi(CV6)\                                                                                                                                                                                                                           
                                                                                                                                                       Zhigou(TE6), Hegu(LI4)\                                                                                                                                                                                                                              
                                                                                                                                                       Liangqiu(ST34), Zusanlli(ST36)\                                                                                                                                                                                                                      
                                                                                                                                                       Shangjuxu(ST37), Fenglong(ST40)\                                                                                                                                                                                                                     
                                                                                                                                                       Sanyinjiao(SP6), Gongsun(SP4)\                                                                                                                                                                                                                       
                                                                                                                                                       Neiting((ST44)                                                                                                                                                                                                                                       

  EA                                Zhongwan(CV12), Xiawan(CV10)\                                                                                      30 min                                                                                                                                           The first 3 days are 1 times a day, and 1 time after 3 days, 15 days is 1 course of treatment.      
                                    Qihai(CV6), Zhongji(CV3)\                                                                                                                                                                                                                                                                                                                                               
                                    Tianshu(ST25), Daheng(SP15) Liangmen(ST21), Huaroumen(ST24) Shuidao(ST28), Quchi(CV6) Zhigou(TE6), Hegu(LI4)\                                                                                                                                                                                                                                                           
                                    Liangqiu(ST34), Zusanlli(ST36) Shangjuxu(ST37), Fenglong(ST40) Sanyinjiao(SP6), Gongsun(SP4) Neiting((ST44)                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                            

  Hsu et al. 2005, Taiwan           EA                                                                                                                 Qihai (REN-6), Shuifen (REN-9) Shuidao (ST-28), Siman (K-14)\                                                                                    40 min                                                                                              2 sessions weekly with a total of 12 sessions for 6 weeks
                                                                                                                                                       Zusanli (ST-26), Fenglong(ST-40)\                                                                                                                                                                                                                    
                                                                                                                                                       Sanginjao (SP-6)                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                            

  Güçel et al. 2012, Turkey         Acupuncture                                                                                                        Hegu(LI4), Shenmen(HT7)\                                                                                                                         20 min                                                                                              2 sessions weekly with a total of 10 sessions for 5 weeks
                                                                                                                                                       Zusanli(ST36), Neiting(ST44) Sanyinjiao(SP6)                                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                                                            

  Deng et al. 2014, China           Combined therapies                                                                                                 Zhongwan (CV 12), Xiawan(CV 10)\                                                                                                                 NR                                                                                                  Acupuncture:1 session every 3 days with a total of 21 sessions for 4 weeks, 3 days rest between every session\
                                                                                                                                                       Qihai(CV 6), Guanyuan( CV4) Huaroumen (ST 24), Wailing ( ST 26)\                                                                                                                                                                                     Acupoint catgut\
                                                                                                                                                       Daheng (SP 15), Tianshu (ST 25)\                                                                                                                                                                                                                     Embedding:1 session weekly with a total of 3 sessions for 3 weeks
                                                                                                                                                       Yinjiao (CV 7), Zhigou (TE 6)\                                                                                                                                                                                                                       
                                                                                                                                                       Zusanll (ST 36)                                                                                                                                                                                                                                      

  Acupuncture                       Zhongwan (CV 12), Xiawan(CV 10)\                                                                                   30 min                                                                                                                                           1 session every 3 days with a total of 21 sessions for 4 weeks, 3 days rest between every session   
                                    Qihai(CV 6), Guanyuan( CV4) Huaroumen (ST 24), Wailing ( ST 26)\                                                                                                                                                                                                                                                                                                        
                                    Daheng (SP 15), Tianshu (ST 25)                                                                                                                                                                                                                                                                                                                                         

  Acupoint catgut embedding         Zhongwan (CV 12), Tianshu (ST 25) Yinjiao (CV 7), Zhigou (TE 6) Guanyuan( CV4), Zusanli (ST 36)                    NR                                                                                                                                               1 session weekly with a total of 3 sessions for 3 weeks                                             

                                                                                                                                                                                                                                                                                                                                                                                                            

  Hassan et al. 2014, Egypt         AR                                                                                                                 NR                                                                                                                                               NR                                                                                                  NR

                                                                                                                                                                                                                                                                                                                                                                                                            

  He et al. 2014, China             AR                                                                                                                 NR                                                                                                                                               NR                                                                                                  NR

  acupuncture                       Tianshu (ST25), Liangmen(ST21) Daheng (SP15), Zusanli (ST36) Sanyinjiao(SP6), Quchi (LI11)\                        30 min                                                                                                                                           1 session daily with a total of 21 sessions for 3 weeks                                             
                                    Zhigou (SJ6), Zhongwan(RN12)\                                                                                                                                                                                                                                                                                                                                           
                                    Qihai (RN06)                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                            

  Wang et al. 2013, China           EA                                                                                                                 Neiting(ST44), Shangjuxu(ST37)\                                                                                                                  30 min                                                                                              1 session every 2 days with a total of 12 sessions for 3 weeks
                                                                                                                                                       Xiajuxu(ST39), Fenglong(ST40)\                                                                                                                                                                                                                       
                                                                                                                                                       Tianshu(ST25), Zusanli(ST36)\                                                                                                                                                                                                                        
                                                                                                                                                       Quchi(LI11)                                                                                                                                                                                                                                          

  Acupuncture                       Neiting(ST44), Shangjuxu(ST37)\                                                                                    30 min                                                                                                                                           1 session every 2 days with a total of 12 sessions for 3 weeks                                      
                                    Xiajuxu(ST39), Fenglong(ST40)\                                                                                                                                                                                                                                                                                                                                          
                                    Tianshu(ST25), Zusanli(ST36)\                                                                                                                                                                                                                                                                                                                                           
                                    Quchi(LI11)                                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                            

  Sujung et al. 2014, South Korea   AAS                                                                                                                Shen-men(TF4), Stomach(CO4) Spleen(CO13), Hunger point Endocrine(C018)                                                                           NR                                                                                                  1 session weekly with a total of 8 sessions for 8 weeks

                                                                                                                                                                                                                                                                                                                                                                                                            

  Bu et al. 2007, China             Combined therapies                                                                                                 Acupuncture:\                                                                                                                                    Acupuncture:30 min\                                                                                 1 session every day with a total of 10 sessions for 6 weeks, 1 week rest in-between 10 sessions.
                                                                                                                                                       Tianshu(ST25), Guanyuan(CV4) Zusanli(ST36), Fenglong(ST40) Sanyinjiao(SP6)\                                                                      ear acupressure:1 day                                                                               
                                                                                                                                                       AAS:\                                                                                                                                                                                                                                                
                                                                                                                                                       Shenmen(TF4), Endocrine(C018) Spleen(CO13), Stomach(CO4) Dachang(CO7), Sanjiao(CO17 )\                                                                                                                                                               
                                                                                                                                                       Naodian                                                                                                                                                                                                                                              

  Acupuncture                       Tianshu(ST25), Guanyuan(CV4) Zusanli(ST36), Fenglong(ST40) Sanyinjiao(SP6)                                         30 min                                                                                                                                           1 session every day with a total of 10 sessions for 6 weeks, 1 week rest in-between 10 sessions.    

                                                                                                                                                                                                                                                                                                                                                                                                            

  Shi et al. 2005, China            Warming acupuncture                                                                                                Zhongwan(CV12), Shuifen(CV9) Qihai(CV6), Zhongji(CV3)\                                                                                           40 min                                                                                              1 session every day with a total of 15 sessions for 4 weeks
                                                                                                                                                       Tianshu(ST25), Shuidao(ST28) Neiguan(PC6), Hegu(LI4) Xuehai(SP10), Zusanli(ST36) Fenglong(ST40), Sanyinjiao(SP6)                                                                                                                                     

  EA                                Zhongwan(CV12), Shuifen(CV9) Qihai(CV6), Zhongji(CV3)\                                                             40 min                                                                                                                                           1 session every day with a total of 15 sessions for 4 weeks                                         
                                    Tianshu(ST25), Shuidao(ST28) Neiguan(PC6), Hegu(LI4) Xuehai(SP10), Zusanli(ST36) Fenglong(ST40), Sanyinjiao(SP6)                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                            

  Yang et al. 2010, China           AR                                                                                                                 Zhongwan(CV12), Tianshu(ST25) Guanyuan(CV4), Zusanli(ST36) Fenglong(ST40), Yinlingquan(SP9) Sanyinjiao(SP6), Pishu(BL20) Weishu(BL21), Ashixue   30 min                                                                                              1 session daily with a total of 15 sessions for 7 weeks, 3 days rest between every session

                                                                                                                                                                                                                                                                                                                                                                                                            

  Cabioglu et al. 2005, Turkey      EA                                                                                                                 Body points:\                                                                                                                                    30 min                                                                                              Body EA was performed everyday, and EA was performed every other day
                                                                                                                                                       Hegu(LI 4), Tianshu(ST 25)\                                                                                                                                                                                                                          
                                                                                                                                                       Quchi(LI 11), Zusanli(ST 36)\                                                                                                                                                                                                                        
                                                                                                                                                       Neiting(ST 44                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                            

  Cabioglu et al. 2006, Turkey      EA                                                                                                                 Body points:\                                                                                                                                    30 min                                                                                              Body EA application was performed daily for 20 days, and EA was applied to each ear on alternating days
                                                                                                                                                       Quchi(LI 11), Zusanli(ST 36)\                                                                                                                                                                                                                        
                                                                                                                                                       Neiting(ST 44)                                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                            

  Cabioglu et al. 2008, Turkey      EA                                                                                                                 Body points:\                                                                                                                                    30 min                                                                                              Body EA application was performed daily for 20 days, and EA was applied to each ear on alternating days
                                                                                                                                                       Hegu(LI 4), Quchi(LI 11)\                                                                                                                                                                                                                            
                                                                                                                                                       Tianshu(ST 25)Zusanli(ST 36)\                                                                                                                                                                                                                        
                                                                                                                                                       Taitong(Liv 3), Neiting(ST 44)                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                            

  Darbandi et al. 2013, Iran        AR                                                                                                                 Inrervention group:\                                                                                                                             20 min                                                                                              Two treatmennt per week for a total of 6 weeks(12 treatments)
                                                                                                                                                       Tianshu(ST 25), Weidao(GB 28)\                                                                                                                                                                                                                       
                                                                                                                                                       Zhongwan(RN 12), Shuifen(RN 9)\                                                                                                                                                                                                                      
                                                                                                                                                       Guanyuan(RN 4), Sanyinjiao(SP 6)\                                                                                                                                                                                                                    
                                                                                                                                                       Excess group:\                                                                                                                                                                                                                                       
                                                                                                                                                       Quchi(LI 11), Fenglong(ST 40)\                                                                                                                                                                                                                       
                                                                                                                                                       Deficiency group:\                                                                                                                                                                                                                                   
                                                                                                                                                       Qihai(RN6), Yinlingquan(SP9)                                                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                                                            

  Fogarty et al. 2015, Australia    AR                                                                                                                 Hegu(LI 4), Quchi(LI 11)\                                                                                                                        NR                                                                                                  NR
                                                                                                                                                       Zusanli(ST 36), Neiting(ST 44)\                                                                                                                                                                                                                      
                                                                                                                                                       Taichong(LR 3)\                                                                                                                                                                                                                                      
                                                                                                                                                       Auricular acupuncture:\                                                                                                                                                                                                                              
                                                                                                                                                       Shenmen(TF4)                                                                                                                                                                                                                                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

LM: lifestyle modification; AAS: auricular acupoint stimulation; EA: electroacupuncture; ACE: acupoint catgut embedding; WA: warming acupuncture; AR: acupuncture and related therapies; \#combination of acupuncture and related therapies.

###### 

Risk of bias assessment.

  Study                             Random sequence generation   Allocation concealment   Blinding of participants and investigators   Blinding of outcome assessment   Incomplete outcome data addressed   Selective outcome reporting
  --------------------------------- ---------------------------- ------------------------ -------------------------------------------- -------------------------------- ----------------------------------- -----------------------------
  Allison et al. 1995, USA          Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Hsu et al. 2005, Taiwan           Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Richards et al. 1998, Australia   Unclear risk                 Low risk                 High risk                                    Low risk                         Low risk                            Unclear risk
  He et al. 2008, China             Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Li et al. 2006, China             Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Tong et al. 2011, China           Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Hsu et al. 2009, Taiwan           Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Hsieh et al. 2010, Taiwan         Unclear risk                 Unclear risk             High risk                                    Low risk                         High risk                           Unclear risk
  Hsieh et al. 2011, Taiwan         Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Abdi et al 2012, Iran             Unclear risk                 Unclear risk             High risk                                    Low risk                         High risk                           Unclear risk
  Darbandi et al 2012, Iran         Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  He et al 2012, China              Unclear risk                 Unclear risk             High risk                                    Low risk                         Unclear risk                        Unclear risk
  Lien et al 2012, Taiwan           Low risk                     Low risk                 High risk                                    Low risk                         High risk                           Unclear risk
  Darbandi et al 2014, Iran         Low risk                     Low risk                 High risk                                    Low risk                         Low risk                            Unclear risk
  Yeh et al. 2015, Taiwan           Low risk                     Low risk                 High risk                                    Low risk                         High risk                           Unclear risk
  Chen et al. 2007, China           Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Huang et al. 2011, China          Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Tang et al. 2009, China           High risk                    Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Shi et al, 2006, China            Low risk                     Unclear risk             High risk                                    Low risk                         Unclear risk                        Unclear risk
  Hsu et al. 2005, Taiwan           Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Güçel et al. 2012, Turkey         Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Deng et al. 2014, China           Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Hassan et al. 2014, Egypt         Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  He et al. 2014, China             Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Wang et al. 2013, China           High risk                    Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Sujung et al. 2014, South Korea   Low risk                     Low risk                 High risk                                    Low risk                         Low risk                            Unclear risk
  Bu et al. 2007, China             Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Shi et al. 2005, China            Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Yang et al. 2010, China           High risk                    Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Cabioglu et al. 2005, Turkey      Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Cabioglu et al. 2006, Turkey      Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Cabioglu et al. 2008, Turkey      Unclear risk                 Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Darbandi et al. 2013, Iran        Low risk                     Unclear risk             High risk                                    Low risk                         Low risk                            Unclear risk
  Fogarty et al. 2015, Australia    Unclear risk                 Low risk                 High risk                                    Low risk                         Low risk                            Unclear risk

###### 

Pairwise meta-analyses.

  Comparison                            Pairwise OR (95% CI)   Number of patients   Number of studies   Heterogeneity test   
  ------------------------------------- ---------------------- -------------------- ------------------- -------------------- -----------
  Body weight                                                                                                                 
   AR vs. LM                            1.66(0.63 to 2.70)     496                  10                  55                   0.02
   AR vs. placebo                       1.15(0.67 to 1.63)     833                  14                  65                   0.0004
   Combines therapies vs. PHA           2.44(-1.98 to 6.86)    80                   1                   \-                   \-
   Acupuncture vs. related therapies    0.25(0.00 to 0.49)     413                  6                   0                    0.73
   Combines therapies vs. acupuncture   1.56(0.07 to 3.05)     378                  6                   99                   \<0.00001
  BMI                                                                                                                         
   AR vs. LM                            1.17(0.09 to 2.26)     314                  6                   74                   0.002
   AR vs. placebo                       0.57(0.40 to 0.74)     830                  12                  63                   0.002
   Combines therapies vs. PHA           0.48(-0.90 to 1.86)    80                   1                   \-                   \-
   Acupuncture vs. related therapies    0.13(-0.06 to 0.32)    325                  5                   0                    0.8
   Combines therapies vs. acupuncture   0.77(-0.37 to 1.92)    158                  4                   88                   \<0.00001

BMI: body mass index; LM: lifestyle modification; PHA: pharmacotherapy; AR: acupuncture and related therapies.

###### 

Results of network meta-analyses.

  Body weight                                                                                                                                                                                                                  
  ----------------------- ----------------------- -------------------------- ----------------------- ----------------------- ----------------------- --------------------------- ---------------------- --------------------- --------
  **AAS**                                                                                                                                                                                                                      
  -1.11 (-4.01, 1.71)     **ACE**                                                                                                                                                                                              
  0.72 (-0.93, 2.37)      1.82 (-1.08, 4.84)      **AR+LM**                                                                                                                                                                    
  -1.45 (-4.11, 1.28)     -0.36 (-1.82, 1.31)     -2.16 (-4.94, 0.61)        **Acupuncture**                                                                                                                                   
  -2.40 (-5.16, 0.35)     -1.28 (-2.96, 0.39)     **-3.09 (-5.97, -0.33)**   -0.92 (-2.34, 0.30)     **Combined theories**                                                                                                     
  -0.07 (-1.85, 1.74)     1.05 (-1.35, 3.48)      -0.77 (-2.61, 1.03)        1.38 (-0.77, 3.57)      **2.33 (0.17, 4.56)**   **EA**                                                                                            
  **1.80 (0.21, 3.41)**   **2.90 (0.16, 5.72)**   1.09 (-0.27, 2.39)         **3.26 (0.65, 5.88)**   **4.18 (1.62, 6.83)**   **1.85 (0.37, 3.37)**   **LM**                                                                    
  0.06 (-5.43, 5.46)      1.11 (-3.79, 6.23)      -0.67 (-6.27, 4.70)        1.47 (-3.37, 6.35)      2.39 (-2.25, 7.16)      0.11 (-5.02, 5.13)      -1.76 (-7.18, 3.51)         **Pharmacotherapy**                           
  **1.26 (0.46, 2.06)**   2.37 (-0.43, 5.18)      0.54 (-0.93, 2.03)         **2.72 (0.06, 5.29)**   **3.65 (0.96, 6.34)**   1.33 (-0.36, 2.96)      -0.55 (-2.02, 0.90)         1.20 (-4.13, 6.63)     **Placebo**            
  -3.47 (-8.46, 1.35)     -2.31 (-7.69, 2.72)     -4.18 (-9.22, 0.67)        -1.99 (-7.32, 2.93)     -1.04 (-6.34, 3.96)     -3.40 (-8.10, 1.06)     **-5.24 (-10.15, -0.55)**   -3.50 (-10.48, 3.39)   -4.72 (-9.77, 0.07)   **WA**
                                                                                                                                                                                                                              
  **BMI**                                                                                                                                                                                                                      
                                                                                                                                                                                                                              
  **AAS**                                                                                                                                                                                                                      
  -0.08 (-1.54, 1.42)     **ACE**                                                                                                                                                                                              
  0.96 (-0.08, 2.00)      1.03 (-0.58, 2.66)      **AR+LM**                                                                                                                                                                    
  -0.64 (-1.48, 0.35)     -0.54 (-1.88, 0.84)     **-1.59 (-2.71, -0.34)**   **Acupuncture**                                                                                                                                   
  -0.81 (-1.77, 0.12)     -0.71 (-2.20, 0.70)     **-1.76 (-2.95, -0.62)**   -0.16 (-1.01, 0.43)     **Combined theories**                                                                                                     
  0.04 (-0.68, 0.78)      0.12 (-1.20, 1.45)      -0.92 (-1.88, 0.08)        0.67 (-0.11, 1.34)      **0.84 (0.19, 1.58)**   **EA**                                                                                            
  **1.31 (0.36, 2.30)**   1.40 (-0.18, 2.96)      0.34 (-0.36, 1.15)         **1.94 (0.83, 3.00)**   **2.12 (1.07, 3.23)**   **1.28 (0.43, 2.11)**   **LM**                                                                    
  -0.31 (-2.14, 1.55)     -0.21 (-2.34, 1.87)     -1.26 (-3.21, 0.79)        0.33 (-1.46, 2.01)      0.51 (-1.06, 2.09)      -0.35 (-2.10, 1.39)     -1.62 (-3.54, 0.31)         **Pharmacotherapy**                           
  **0.63 (0.25, 1.11)**   0.72 (-0.71, 2.15)      -0.32 (-1.28, 0.69)        **1.28 (0.43, 2.05)**   **1.44 (0.64, 2.38)**   **0.60 (0.03, 1.22)**   -0.66 (-1.58, 0.26)         0.95 (-0.85, 2.78)     **Placebo**            

BMI: body mass index; LM: lifestyle modification; AAS: auricular acupoint stimulation; EA: electroacupuncture; ACE: acupoint catgut embedding; WA: warming acupuncture; AR: acupuncture and related therapies; combined therapies: combination of acupuncture and related therapies.

[^1]: Academic Editor: Mariangela Rondanelli
